312 related articles for article (PubMed ID: 36844398)
1. Gut microbiota in patients with COVID-19 and type 2 diabetes: A culture-based method.
Petakh P; Kobyliak N; Kamyshnyi A
Front Cell Infect Microbiol; 2023; 13():1142578. PubMed ID: 36844398
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic, Prognostic, and Therapeutic Roles of Gut Microbiota in COVID-19: A Comprehensive Systematic Review.
Farsi Y; Tahvildari A; Arbabi M; Vazife F; Sechi LA; Shahidi Bonjar AH; Jamshidi P; Nasiri MJ; Mirsaeidi M
Front Cell Infect Microbiol; 2022; 12():804644. PubMed ID: 35310853
[TBL] [Abstract][Full Text] [Related]
3. Trans-ethnic gut microbiota signatures of type 2 diabetes in Denmark and India.
Alvarez-Silva C; Kashani A; Hansen TH; Pinna NK; Anjana RM; Dutta A; Saxena S; Støy J; Kampmann U; Nielsen T; Jørgensen T; Gnanaprakash V; Gnanavadivel R; Sukumaran A; Rani CSS; Færch K; Radha V; Balasubramanyam M; Nair GB; Das B; Vestergaard H; Hansen T; Mande SS; Mohan V; Arumugam M; Pedersen O
Genome Med; 2021 Mar; 13(1):37. PubMed ID: 33658058
[TBL] [Abstract][Full Text] [Related]
4. Metformin Therapy Changes Gut Microbiota Alpha-Diversity in COVID-19 Patients with Type 2 Diabetes: The Role of SARS-CoV-2 Variants and Antibiotic Treatment.
Petakh P; Kamyshna I; Oksenych V; Kainov D; Kamyshnyi A
Pharmaceuticals (Basel); 2023 Jun; 16(6):. PubMed ID: 37375851
[TBL] [Abstract][Full Text] [Related]
5. The F/B ratio as a biomarker for inflammation in COVID-19 and T2D: Impact of metformin.
Petakh P; Oksenych V; Kamyshnyi A
Biomed Pharmacother; 2023 Jul; 163():114892. PubMed ID: 37196542
[TBL] [Abstract][Full Text] [Related]
6. Gut microbiota varies by opioid use, circulating leptin and oxytocin in African American men with diabetes and high burden of chronic disease.
Barengolts E; Green SJ; Eisenberg Y; Akbar A; Reddivari B; Layden BT; Dugas L; Chlipala G
PLoS One; 2018; 13(3):e0194171. PubMed ID: 29596446
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive relationships between gut microbiome and faecal metabolome in individuals with type 2 diabetes and its complications.
Zhao L; Lou H; Peng Y; Chen S; Zhang Y; Li X
Endocrine; 2019 Dec; 66(3):526-537. PubMed ID: 31591683
[TBL] [Abstract][Full Text] [Related]
8. Combined effects of
Shin NR; Gu N; Choi HS; Kim H
Am J Physiol Endocrinol Metab; 2020 Jan; 318(1):E52-E61. PubMed ID: 31770016
[TBL] [Abstract][Full Text] [Related]
9. Snapshot into the Type-2-Diabetes-Associated Microbiome of a Romanian Cohort.
Gradisteanu Pircalabioru G; Chifiriuc MC; Picu A; Petcu LM; Trandafir M; Savu O
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499348
[TBL] [Abstract][Full Text] [Related]
10. Baseline gut microbiome composition predicts metformin therapy short-term efficacy in newly diagnosed type 2 diabetes patients.
Elbere I; Silamikelis I; Dindune II; Kalnina I; Ustinova M; Zaharenko L; Silamikele L; Rovite V; Gudra D; Konrade I; Sokolovska J; Pirags V; Klovins J
PLoS One; 2020; 15(10):e0241338. PubMed ID: 33125401
[TBL] [Abstract][Full Text] [Related]
11. Gut Microbiota and Subclinical Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus.
Tsai HJ; Tsai WC; Hung WC; Hung WW; Chang CC; Dai CY; Tsai YC
Nutrients; 2021 Aug; 13(8):. PubMed ID: 34444839
[TBL] [Abstract][Full Text] [Related]
12. Metformin Reduces Blood Glucose in Treatment-Naive Type 2 Diabetes by Altering the Gut Microbiome.
He D; Han H; Fu X; Liu A; Zhan Y; Qiu H; Ma L; Zhang X; Wang X
Can J Diabetes; 2022 Mar; 46(2):150-156. PubMed ID: 35148952
[TBL] [Abstract][Full Text] [Related]
13. Metformin-induced changes of the gut microbiota in healthy young men: results of a non-blinded, one-armed intervention study.
Bryrup T; Thomsen CW; Kern T; Allin KH; Brandslund I; Jørgensen NR; Vestergaard H; Hansen T; Hansen TH; Pedersen O; Nielsen T
Diabetologia; 2019 Jun; 62(6):1024-1035. PubMed ID: 30904939
[TBL] [Abstract][Full Text] [Related]
14. Considering gut microbiota in treatment of type 2 diabetes mellitus.
Adeshirlarijaney A; Gewirtz AT
Gut Microbes; 2020 May; 11(3):253-264. PubMed ID: 32005089
[TBL] [Abstract][Full Text] [Related]
15. Gut dysbiosis, inflammation and type 2 diabetes in mice using synthetic gut microbiota from diabetic humans.
Liaqat I; Ali NM; Arshad N; Sajjad S; Rashid F; Hanif U; Ara C; Ulfat M; Andleeb S; Awan UF; Bibi A; Mubin M; Ali S; Tahir HM; Ul-Haq I
Braz J Biol; 2021; 83():e242818. PubMed ID: 34378656
[TBL] [Abstract][Full Text] [Related]
16. Coronavirus Disease (COVID-19) Caused by (SARS-CoV-2) Infections: A Real Challenge for Human Gut Microbiota.
Vodnar DC; Mitrea L; Teleky BE; Szabo K; Călinoiu LF; Nemeş SA; Martău GA
Front Cell Infect Microbiol; 2020; 10():575559. PubMed ID: 33363049
[TBL] [Abstract][Full Text] [Related]
17. Differences in gut microbiota and its metabolic function among different fasting plasma glucose groups in Mongolian population of China.
Liu Y; Wang M; Li W; Gao Y; Li H; Cao N; Hao W; Zhao L
BMC Microbiol; 2023 Apr; 23(1):102. PubMed ID: 37060052
[TBL] [Abstract][Full Text] [Related]
18. Changes of Gut Microbiota in Maintenance Hemodialysis Patients and Their Impact on Patient's Microinflammation Status.
Zhang X; Wang Y; Yin Y; Sun B; Chen G; Chen F
Cell Mol Biol (Noisy-le-grand); 2023 Aug; 69(8):96-101. PubMed ID: 37715414
[TBL] [Abstract][Full Text] [Related]
19. The Relationship Between Pediatric Gut Microbiota and SARS-CoV-2 Infection.
Romani L; Del Chierico F; Macari G; Pane S; Ristori MV; Guarrasi V; Gardini S; Pascucci GR; Cotugno N; Perno CF; Rossi P; Villani A; Bernardi S; Campana A; Palma P; Putignani L;
Front Cell Infect Microbiol; 2022; 12():908492. PubMed ID: 35873161
[TBL] [Abstract][Full Text] [Related]
20. Response of gut microbiota in type 2 diabetes to hypoglycemic agents.
Zhang F; Wang M; Yang J; Xu Q; Liang C; Chen B; Zhang J; Yang Y; Wang H; Shang Y; Wang Y; Mu X; Zhu D; Zhang C; Yao M; Zhang L
Endocrine; 2019 Dec; 66(3):485-493. PubMed ID: 31410749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
